References
- Kahlmeter G, Dahlager JI. Aminoglycoside toxicity – a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother;(Suppl A) 1984; 13: 9–22
- Forge A, Schacht J. Aminoglycoside antibiotics. Audiol Neurootol 2000; 5: 3–22
- Priuska EM, Schacht J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol 1995; 50: 1749–52
- Danson EJ, Paterson DJ. Reactive oxygen species and autonomic regulation of cardiac excitability. J Cardiovasc Electrophysiol 2006; 17(Suppl 1)S104–S112
- Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005; 11: 3141–58
- Takumida M, Anniko M, Shimizu A, Watanabe H. Neuroprotection of vestibular sensory cells from gentamicin ototoxicity obtained using nitric oxide synthase inhibitors, reactive oxygen species scavengers, brain-derived neurotrophic factors and calpain inhibitors. Acta Otolaryngol 2003; 123: 8–13
- Rybak LP, Whitworth C, Somani S. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 1999; 109: 1740–4
- Takumida M, Anniko M. Protective effect of edaravone against the ototoxicity of Pseudomonas aeruginosa exotoxin A. Acta Otolaryngol 2006; 126: 15–19
- Takemoto T, Sugahara K, Okuda T, Shimogori H, Yamashita H. The clinical free radical scavenger, edaravone, protects cochlear hair cells from acoustic trauma. Eur J Pharmacol 2004; 487: 113–16
- Sha S-H SJ. Antioxidant attenuates free radical formation in vitro and ototoxicity in vivo: D-methionine is a potent protectant. Hear Res 2000; 142: 34–40
- Abe S, Kirima K, Tsuchiya K, Okamoto M, Hasegawa T, Houchi H, et al. The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazoline-5-one (MCI-186)) with hydroxyl radical. Chem Pharm Bull (Tokyo) 2004; 52: 186–91
- Maetani T, Hakuba N, Taniguchi M, Hyodo J, Shimizu Y, Gyo K. Free radical scavenger protects against inner hair cell loss after cochlear ischemia. Neuroreport 2003; 14: 1881–4
- Mishina M, Komaba Y, Kobayashi S, Tanaka N, Kominami S, Fukuchi T, et al Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction. Neurol Med Chir (Tokyo) 2005;45:344–8; dicussion 8.
- Tsujita K, Shimomura H, Kawano H, Hokamaki J, Fukuda M, Yamashita T, et al. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004; 94: 481–4
- Arii K, Kumon Y, Ikeda Y, Suehiro T, Hashimoto K. Edaravone inhibits the disease activity in rheumatoid arthritis. J Clin Pharm Ther 2006; 31: 197–9
- Stenqvist M, Anniko M, Pettersson A. Electrophysiological effects of multiple instillation of Haemophilus influenzae type b endotoxin on the inner ear. Acta Otolaryngol 1997; 117: 352–7
- Yamashita D, Jiang HY, Schacht J, Miller JM. Delayed production of free radicals following noise exposure. Brain Res 2004; 1019: 201–9
- Horiike O, Shimogori H, Yamashita H. Effect of edaravone on streptomycin-induced vestibulotoxicity in the guinea pig. Laryngoscope 2004; 114: 1630–2
- Usami S, Hjelle OP, Ottersen OP. Differential cellular distribution of glutathione – an endogenous antioxidant – in the guinea pig inner ear. Brain Res 1996; 743: 337–40
- Sha SH, Taylor R, Forge A, Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 2001; 155: 1–8
- Jiang H, Sha SH, Schacht J. NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J Neurosci Res 2005; 79: 644–51
- Dormans JA, Peters-Volleberg GW, Dortant PM, Speijers GJ. Ototoxicity of tobramycin in young adult and old rats. Toxicol Appl Pharmacol 1996; 136: 179–85